The results come as Pfizer and other drugmakers grapple with Trump’s calls to lower U.S. drug prices and brace for his planned tariffs on pharmaceuticals.
Recent Posts
- Oil giant Equinor backs crisis-stricken Orsted as Trump lashes out at offshore wind
- Trump keeps threatening to punish Putin. Here’s what’s holding him back
- European markets climb as UK-Norway warship deal lifts defense shares
- China’s Xi urges AI cooperation, rejects ‘Cold War mentality’ at SCO summit
- ‘Dear Canada’: U.S. tourist spots try to win back neighbors from the north